ANIMAL CARCINOGENICITY EXPERIMENTS WITH AND WITHOUT SERIAL SACRIFICE

被引:5
作者
MALANI, HM
LU, Y
机构
[1] UNIV CALIF BERKELEY,BERKELEY,CA 94720
[2] UNIV MIAMI,DEPT EPIDEMIOL & PREVENT MED,DIV BIOSTAT,MIAMI,FL 33101
关键词
ED01; STUDY; HOEL-WALBURG TEST OF TUMOR PREVALENCE; DEATH RATE WITH TUMOR; TUMOR INCIDENCE RATE; SURVIVAL SACRIFICE EXPERIMENTS; OCCULT TUMORS; POWER;
D O I
10.1080/03610929308831103
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Commonly used tests to detect carcinogenic potential of a test compound make extreme assumptions about the lethality of tumors, due to their occult nature. In this paper we compare a nonparametric test, which uses interim sacrifice to avoid such assumptions, with these tests using simulation based on the ED01 data. Results indicate that in the presence of a significant difference in the mortality rate with treatment, commonly used methods could fail to maintain the nominal significance level. However, when there is no difference in the mortality rate, such procedures are robust to the underlying assumptions about the lethality of tumors and more powerful than the nonparametric test using interim sacrifice.
引用
收藏
页码:1557 / 1584
页数:28
相关论文
共 20 条
[1]   EFFECTS OF TREATMENT-INDUCED MORTALITY AND TUMOR-INDUCED MORTALITY ON TESTS FOR CARCINOGENICITY IN SMALL SAMPLES [J].
BAILER, AJ ;
PORTIER, CJ .
BIOMETRICS, 1988, 44 (02) :417-431
[2]  
CAIRNS T, 1980, J ENVIRON PATHOL TOX, V3, P1
[3]   NONPARAMETRIC METHODS FOR SURVIVAL SACRIFICE EXPERIMENTS [J].
DEWANJI, A ;
KALBFLEISCH, JD .
BIOMETRICS, 1986, 42 (02) :325-341
[4]   NONPARAMETRIC-ESTIMATION OF LIFETIME AND DISEASE ONSET DISTRIBUTIONS FROM INCOMPLETE OBSERVATIONS [J].
DINSE, GE ;
LAGAKOS, SW .
BIOMETRICS, 1982, 38 (04) :921-932
[5]   CONSTANT RISK DIFFERENCES IN THE ANALYSIS OF ANIMAL TUMORIGENICITY DATA [J].
DINSE, GE .
BIOMETRICS, 1991, 47 (02) :681-700
[6]  
DINSE GE, 1988, J AM STAT ASSOC, V83, P638
[7]  
Gart J.J., 1986, IARC SCI PUBLICATION, V79
[8]  
GAYLOR DW, 1980, J ENVIRON PATHOL TOX, V3, P1179
[9]  
HOEL DG, 1972, JNCI-J NATL CANCER I, V49, P361
[10]  
JOHNSON SB, 1980, J BEHAV MED, V3, P9